Aspergillosis complicating severe influenza infection has been increasingly detected
worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has …

Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Background Fungal coinfection is a recognized complication of respiratory virus infections,
increasing morbidity and mortality, but can be readily treated if diagnosed early. An …

The coronavirus disease 2019 (COVID-19) virus caused a wide spectrum of disease in
healthy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is …

COVID-19-associated pulmonary aspergillosis (CAPA) is a recently described disease entity
affecting patients with severe pulmonary abnormalities treated in intensive care units …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …

Abstract Detection of 1, 3-β-d-glucan (BDG) in serum has been evaluated for its inclusion as
a mycological criterion of invasive fungal infections (IFI) according to EORTC and Mycoses …

Background Invasive aspergillosis (IA) is a life‐threatening opportunistic mycosis that occurs
in some people with a compromised immune system. The serum galactomannan enzyme …

Methods Between January 2020 and May 2021, data of severely to critically ill COVID-19
patients were extracted from seven hospitals of the Catholic Medical Center through a …

Invasive pulmonary aspergillosis (IPA) is an emerging and life-threatening infectious
disease in patients admitted to the intensive care unit (ICU). Most diagnostic studies are …